JY
RNXT icon

Jeff Yass’s RenovoRx RNXT Stock Holding History

Jeff Yass’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-90,009
Closed -$75.6K – 13972
2025
Q4 		$75.6K Buy
+90,009
New +$90.1K ﹤0.01% 11590
2023
Q4 		– Sell
-10,340
Closed -$13K – 13167
2023
Q3 		$13K Sell
10,340
-2,023
-16% -$3.64K ﹤0.01% 11690
2023
Q2 		$27.9K Buy
+12,363
New +$30K ﹤0.01% 11542
2022
Q2 		– Sell
-18,582
Closed -$54K – 13797
2022
Q1 		$54K Buy
+18,582
New +$65.1K ﹤0.01% 12278

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Jeff Yass's RNXT Position: Q1 2026 in Review

Jeff Yass sold out of RenovoRx (RNXT) in Q1 2026, closing a stake of 90,009 shares — an estimated $75.6K sold.

Jeff Yass first reported a position in RNXT in Q1 2022 and held it in 4 quarters. The position peaked at $75.6K in Q4 2025. 31 funds tracked by Wall St. Rank hold RNXT as of Q1 2026.

  • Jeff Yass reported no remaining RenovoRx position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 90,009 RenovoRx shares in Q1 2026, an estimated $75.6K.
  • Jeff Yass first reported a position in RenovoRx in Q1 2022 and held it in 4 quarters.
  • Jeff Yass's RenovoRx position peaked at $75.6K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held RenovoRx as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.